Chimaeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy.
Gross
G
G
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Levy
S
S
Levy
R
R
Waks
T
T
Eshhar
Z
Z
D000818:Animals; D004195:Disease Models, Animal; D006825:Hybridomas; D007130:Immunoglobulin Idiotypes; D007167:Immunotherapy; D007376:Interleukin-2 / Q000378:metabolism; D016393:Lymphoma, B-Cell / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D051379:Mice; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D014162:Transfection
D007130:Immunoglobulin Idiotypes; D007376:Interleukin-2; D011948:Receptors, Antigen, T-Cell; D011993:Recombinant Fusion Proteins